A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Name: A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
License: Public Domain

Pfizer

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

chronickidneydisease

chronic renal failure, chronic kidney disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405238
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.